Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Regular ✕Edelweiss Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundEdelweiss Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseTataEdelweiss
NAV₹33.9323₹9.2021
NAV date20 Nov 202620 Nov 2026
History10.9 years2.3 years
Expense ratio2.4%2.7%
Stars★★★★★Not rated
Growth Score65.70—

Returns

Tata India Pharma & Healthcare FundEdelweiss Business Cycle Fund
1 month+9.73%+5.71%
3 months+0.76%+0.80%
6 months+6.88%+4.95%
YTD+12.33%+1.69%
1 year+10.25%+2.20%
3 years (CAGR)+17.02%—
5 years (CAGR)+14.30%—
10 years (CAGR)+14.17%—
Since launch+11.82%−3.74%

Risk

Tata India Pharma & Healthcare FundEdelweiss Business Cycle Fund
Volatility15.7%—
Downside volatility10.1%—
Sharpe0.67—
Sortino1.04—
Calmar1.00—
Return / risk1.09—
Deepest fall−21.94%−26.91%
Days to recover624—
Below its high−0.20%−10.68%

Against benchmark

Tata India Pharma & Healthcare FundEdelweiss Business Cycle Fund
Alpha−4.21%—
Beta1.00—
R²90.2%—
Up capture88.9%—
Down capture105.4%—
Tracking error4.9%—
Information ratio−0.87—
Treynor0.09—

Consistency

Tata India Pharma & Healthcare FundEdelweiss Business Cycle Fund
Best 1-year+73.72%+19.06%
Middle 1-year+7.27%−0.57%
Worst 1-year−18.70%−16.02%
1-year periods with a loss33.4%51.7%
Middle 3-year+19.29%—
Positive months61.1%—
Best day+3.33%+4.77%
Worst day−3.10%−3.86%
Worst 5% day−1.35%−2.02%
Positive days54.9%53.1%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundEdelweiss Business Cycle Fund
5-year XIRR+16.33%—
5-year value₹9,09,680—
3-year XIRR+11.67%—
1-year XIRR+16.78%+7.48%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth